17/06/2017
Dasiglucagon (pINN) presentation at the 77th Scientific Sessions of the American Diabetes Association (ADA) indicate use for treatment of severe hypoglycemia
Zealand Pharma ("Zealand") and lead scientist on the investigational side, Dr. Tim Heise of Profil Neuss, will today present elaborated data from the Phase 2 trial of dasiglucagon in patients with type 1 diabetes to treat insulin-induced hypoglycemia at [...]
